Physiological Saline Market Report 2026

The physiological saline market size has grown strongly in recent years. It will grow from $7.09 billion in 2025 to $7.71 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to expansion of hospital and clinic networks, rising use of intravenous therapies, increasing surgical procedure volumes, growing demand for emergency medical supplies, improvements in pharmaceutical manufacturing capacity.

The physiological saline market size is expected to see strong growth in the next few years. It will grow to $10.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand from chronic disease management, rising focus on infection control practices, expansion of outpatient and home care services, growing investments in pharmaceutical automation, increasing emphasis on supply chain resilience. Major trends in the forecast period include increasing demand for sterile and ready-to-use solutions, rising adoption of large-volume infusion products, growing focus on quality and safety standards, expansion of automated saline production processes, enhanced emphasis on supply chain reliability.

The increase in surgical procedures is expected to propel the growth of the physiological saline market going forward. Surgical procedures are medical interventions carried out by trained healthcare professionals to diagnose, treat, or correct diseases, injuries, or abnormalities through invasive techniques such as incisions, excisions, suturing, or other manipulations. The growing number of surgical procedures can be attributed to advancements in surgical methods, improved access to healthcare services, and an aging population with greater medical requirements, all of which are driving demand for surgical interventions. Physiological saline is widely used during surgical procedures for wound cleansing, tissue hydration, and irrigation purposes. For instance, in April 2024, according to the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK-based professional organization, cosmetic surgical volumes increased by 5% year on year, reaching 27,462 procedures performed in 2024. Therefore, the rise in surgical procedures is driving the growth of the physiological saline market.

Major companies operating in the physiological saline market are focusing on developing innovative products, such as premixed hypertonic saline, which offers a ready-to-use solution that enables healthcare professionals to administer accurate saline dosages more easily and safely, particularly in emergency situations. Premixed hypertonic saline refers to a saline solution with a higher sodium chloride concentration than normal saline that is prepared in advance for clinical use. It is commonly used to manage conditions such as hyponatremia or to support pulmonary therapies. For instance, in April 2024, Delex Pharma International Inc., a US-based pharmaceutical manufacturing company, launched Axaline (Sodium Chloride), the first premixed 3% hypertonic saline solution for severe hyponatremia. Axaline delivers effective electrolyte replenishment for conditions including hyponatremia, hypochloremia, and low salt syndrome.

In January 2023, Prestige Ameritech, a US-based manufacturer of disposable medical devices and automated machinery, acquired Anexa Biomedical for an undisclosed amount. Through this acquisition, Prestige Ameritech expanded its healthcare solutions portfolio to include sterile water and sterile saline, products that have historically faced supply shortages. Anexa Biomedical is a US-based manufacturer specializing in saline solutions and sterile water.

Major companies operating in the physiological saline market are Cardinal Health Inc., Pfizer Inc., Fresenius Kabi AG, Merck KGaA, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd, Grifols S.A., B Braun Medical Inc, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Pfizer Hospira Inc., JW Pharmaceutical Corporation, Kelun Pharmaceutical Co. Ltd, Sichuan Kelun Pharmaceutical Co. Ltd, ICU Medical Inc., Nipro Corporation, Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Lupin Ltd.

North America was the largest region in the physiological saline market in 2025. The regions covered in the physiological saline market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the physiological saline market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the physiological saline market by increasing costs of imported pharmaceutical-grade raw materials, packaging components, sterilization equipment, and filling machinery. Healthcare systems in North America and Europe are most affected due to reliance on imported production inputs, while Asia-Pacific faces higher costs for export-oriented saline manufacturing. These tariffs are increasing production expenses and impacting pricing stability. However, they are also encouraging domestic saline production, localized sourcing of packaging materials, and investments in regional pharmaceutical manufacturing capacity.

The physiological saline market research report is one of a series of new reports that provides physiological saline market statistics, including physiological saline industry global market size, regional shares, competitors with a physiological saline market share, detailed physiological saline market segments, market trends and opportunities, and any further data you may need to thrive in the physiological saline industry. This physiological saline market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Physiological saline, also known as saline solution, is a sterile mixture of sodium chloride dissolved in water at a concentration that closely matches that of the human body. It is widely used in medical settings for purposes such as wound cleaning, intravenous infusion, medication dilution, and irrigation of body cavities during surgical procedures. Physiological saline plays a vital role in maintaining hydration, electrolyte balance, and proper cellular function, making it an essential component of patient care, medical interventions, and emergency treatments across healthcare environments.

The main types of physiological saline include normal saline, hypertonic saline, and hypotonic saline. Normal saline, also referred to as isotonic saline, contains 0.9% sodium chloride in water and closely mirrors the salt concentration found in human blood. Physiological saline is applied in the management of acute health conditions, chronic diseases, skin abrasions, burns, and other uses, and it is utilized by various end users such as hospitals, clinics, recovery centers, and others.

The physiological saline market consists of sales of sterile saline solution, saline nasal spray, and saline eye drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.